Trial · NCT01347580
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Thrombolysis In Myocardial Infarction (TIMI) Flow Grade 3 of MI Culprit Vessel at Initial Angiography (Co-primary Endpoint) | Pre-hospital Ticagrelor | 143 | patients | ||
| Thrombolysis In Myocardial Infarction (TIMI) Flow Grade 3 of MI Culprit Vessel at Initial Angiography (Co-primary Endpoint) | In-hospital Ticagrelor | 145 | patients | ||
| ST-segment Elevation Resolution Pre PCI ≥70% (Co-primary Endpoint) | Pre-hospital Ticagrelor | 102 | patients | ||
| ST-segment Elevation Resolution Pre PCI ≥70% (Co-primary Endpoint) | In-hospital Ticagrelor | 102 | patients | ||
| 1st Composite Clinical Endpoint | Pre-hospital Ticagrelor | 41 | patients | ||
| 1st Composite Clinical Endpoint | In-hospital Ticagrelor | 42 | patients | ||
| 2nd Composite Clinical Endpoint | Pre-hospital Ticagrelor | 39 | patients | ||
| 2nd Composite Clinical Endpoint | In-hospital Ticagrelor | 34 | patients | ||
| Definite Stent Thrombosis | Pre-hospital Ticagrelor | 2 | patients | ||
| Definite Stent Thrombosis | In-hospital Ticagrelor | 11 | patients | ||
| TIMI Flow Grade 3 Post -PCI | Pre-hospital Ticagrelor | 625 | patients | ||
| TIMI Flow Grade 3 Post -PCI | In-hospital Ticagrelor | 630 | patients | ||
| ST Segment Elevation Resolution Post-PCI >= 70% | Pre-hospital Ticagrelor | 410 | patients | ||
| ST Segment Elevation Resolution Post-PCI >= 70% | In-hospital Ticagrelor | 390 | patients | ||
| Thrombotic Bail-out With GPIIb/IIIa Inhibitors at Initial PCI | Pre-hospital Ticagrelor | 78 | patients | ||
| Thrombotic Bail-out With GPIIb/IIIa Inhibitors at Initial PCI | In-hospital Ticagrelor | 100 | patients | ||
| Major Bleeds Within 48 Hours | Pre-hospital Ticagrelor | 16 | patients | ||
| Major Bleeds Within 48 Hours | In-hospital Ticagrelor | 15 | patients | ||
| Minor and Major Bleedings Within 48 Hours | Pre-hospital Ticagrelor | 24 | patients | ||
| Minor and Major Bleedings Within 48 Hours | In-hospital Ticagrelor | 24 | patients |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01347580/results